USP 14 inhibition corrects an in vivo model of impaired mitophagy-Reference-Cited by-同舟云学术

USP 14 inhibition corrects an in vivo model of impaired mitophagy

Published:2018-09-24 Issue:11 Volume:10 Page:
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Chakraborty Joy¹,Stockum Sophia²,Marchesan Elena²,Caicci Federico¹,Ferrari Vanni¹,Rakovic Aleksandar³,Klein Christine³,Antonini Angelo⁴,Bubacco Luigi¹,Ziviani Elena¹²^ORCID

Affiliation:

1. Department of Biology University of Padova Padova Italy

2. Fondazione Ospedale San Camillo IRCCS Venezia Italia

3. Institute of Neurogenetics University of Lübeck Lübeck Germany

4. Department of Neuroscience University of Padova Padova Italy

Funder

Ministry of Health

Michael J. Fox Foundation for Parkinson's Research

Publisher

EMBO

Subject

Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.15252/emmm.201809014

Reference58 articles.

1. The needless PINK1

2. The mitochondrial deubiquitinase USP30 opposes parkin-mediated mitophagy

3. An inhibitor of the proteasomal deubiquitinating enzyme USP14 induces tau elimination in cultured neurons

4. Mitofusin 2 tethers endoplasmic reticulum to mitochondria

5. Dephosphorylation by calcineurin regulates translocation of Drp1 to mitochondria

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological inhibition of USP14 delays proteostasis-associated aging in a proteasome-dependent but foxo-independent manner;Autophagy;2024-08-15

2. Usp14 down-regulation corrects sleep and circadian dysfunction of a Drosophila model of Parkinson’s disease;Frontiers in Neuroscience;2024-08-05

3. Inhibition of Usp14 ameliorates renal ischemia-reperfusion injury by reducing Tfap2a stabilization and facilitating mitophagy;Translational Research;2024-08

4. Structural Dynamics of the Ubiquitin Specific Protease USP30 in Complex with a Cyanopyrrolidine-Containing Covalent Inhibitor;2024-07-20

5. Emerging perspectives on precision therapy for Parkinson’s disease: multidimensional evidence leading to a new breakthrough in personalized medicine;Frontiers in Aging Neuroscience;2024-07-04